Vynleads (VYND) Receivables (2019 - 2024)
Vynleads' (VYND) quarterly Receivables came in at $9434.0 in Q4 2024, down 46.29% on a QoQ basis from $17564.0 in Q4 2020.
Vynleads (VYND) Receivables (2019 - 2024) Analysis & Trends
Vynleads (VYND) has 3 years of Receivables data on file, last reported at $9434.0 in Q4 2024.
- On a quarterly basis, Receivables changed N/A year-over-year to $9434.0 in Q4 2024; TTM through Dec 2024 was $9434.0, a N/A change from a year earlier, with the FY2024 full-year figure at $9434.0, changed N/A from the prior year.
- Receivables for Q4 2024 stood at $9434.0, down from $17564.0 in the prior quarter.
- Over the last five years, Receivables for VYND reached as high as $48514.0 in Q1 2020 and fell as low as $9434.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.90 Bn | 25.59 Bn | 662.02 Mn | 627.77 Mn |
| 2 | Healthequity | 8.58 Bn | 8.31 Bn | 256.31 Mn | 122.00 Mn |
| 3 | 10x Genomics | 6.00 Bn | 5.46 Bn | 106.18 Mn | 20.90 Mn |
| 4 | Hinge Health | 5.92 Bn | 5.61 Bn | 154.23 Mn | 166.20 Mn |
| 5 | MiniMed | 4.60 Bn | 4.31 Bn | 480.00 Mn | 655.00 Mn |
| 6 | Waystar Holding | 4.55 Bn | 4.49 Bn | 216.84 Mn | 172.53 Mn |
| 7 | Doximity | 4.00 Bn | 3.25 Bn | 125.97 Mn | 146.98 Mn |
| 8 | Privia Health | 3.08 Bn | 2.66 Bn | - | 513.68 Mn |
| 9 | Omnicell | 1.94 Bn | 1.70 Bn | 140.36 Mn | 281.63 Mn |
| 10 | Vynleads | 7.51 Mn | 7.51 Mn | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9,434.00 |
| Dec 31, 2020 | 17,564.00 |
| Sep 30, 2020 | 30,904.00 |
| Jun 30, 2020 | 39,545.00 |
| Mar 31, 2020 | 48,514.00 |
| Dec 31, 2019 | 45,919.00 |